Literature DB >> 8642818

Reoperation after valve repair for mitral regurgitation: early and intermediate results.

R J Cerfolio1, T A Orzulak, J R Pluth, W S Harmsen, H V Schaff.   

Abstract

To better understand late outcomes of mitral valve repair, we reviewed the cases of 49 consecutive patients who underwent reoperation between January 1974 and May 1992 for recurrent valve dysfunction after previous valvuloplasty for mitral regurgitation. There were 27 men (55%) and 22 women, with a median age of 63 years (range 20 to 84 years). Original procedures included annuloplasty and posterior leaflet repair in 15 patients (31%), annuloplasty and anterior leaflet repair in 15 (31%), commissural plication in 13 (27%), and complex bileaflet repairs in six (12%). Median time between initial mitral repair and reoperation was 2.4 years (range 2 months to 25.3 years). Indications for reoperation included recurrent severe mitral regurgitation in 34 patients (70%), hemolytic anemia from mitral regurgitation in seven (14%), mixed mitral regurgitation and stenosis in seven (14%), and isolated mitral stenosis in one (2%). Before reoperation, 36 patients were in New York Heart Association functional class III and 11 were in class IV. Initial repairs were intact at the second operation in 32 patients (65%), and the etiology of recurrent mitral regurgitation in these patients was fibrosis or calcification of the anulus or leaflets in 22 patients, newly ruptured chordae in seven, and perforated leaflets in three. The causes of mitral regurgitation in the 17 patients whose initial repair had failed included dehiscence of commissural repairs in nine patients, dehiscence of ring annuloplasty in four, and break-down of chordal or leaflet repair in four. Patients with original repairs involving the anterior leaflet had a significantly shorter time between operations (p = 0.006). In eight patients (16%), the mitral valve was repaired again; in the remaining 41 patients (84%), prosthetic replacement was performed. Operative mortality rate was 4% (two patients). All eight patients who underwent mitral valve rerepair had no mitral regurgitation, trivial regurgitation, or mild regurgitation at discharge from the hospital. Follow-up was 100% complete at a mean of 5.1 years (range 1 to 19 years). Forty-one patients (87% were in New York Heart Association functional class I or II, and survival at 5 years was 75.3%. Of the eight patients who underwent a second repair, seven had no regurgitation, trivial regurgitation, or mild regurgitation at a median of 4 years' follow-up. The low mortality associated with reoperation supports an aggressive approach toward mitral regurgitation with initial repair. A second repair can be performed in selected patients with durable results at 4 years.

Entities:  

Mesh:

Year:  1996        PMID: 8642818     DOI: 10.1016/s0022-5223(96)70219-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Rerepair for recurrent mitral regurgitation due to Physio ring dehiscence.

Authors:  Akira Saito; Seiichiro Katahira; Kazuhiko Hirata; Masaya Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-02

2.  Do all hemolytic anemias that occur after mitral valve repair require surgical treatment?

Authors:  Askin Gungunes; Ibrahim Akpinar; Mehmet Dogan; Kazim Baser; Ismail Safa Yildirim; Ibrahim C Haznedaroglu
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

Review 3.  Current concepts in mitral valve repair for degenerative disease.

Authors:  David H Adams; Anelechi C Anyanwu; Parwis B Rahmanian; Farzan Filsoufi
Journal:  Heart Fail Rev       Date:  2006-09       Impact factor: 4.214

4.  Reoperation after mitral valve repair in viewpoints of kidney injury as well as hemolytic anemia.

Authors:  Ryo Ishida; Takaomi Adachi; Yayoi Shiotsu; Mami Ishida; Yasukiyo Mori; Kiyoshi Doi; Keiichi Tamagaki
Journal:  CEN Case Rep       Date:  2014-10-18

Review 5.  The long-term outcome of mitral valve repair for mitral valve prolapse.

Authors:  Dania Mohty; Maurice Enriquez-Sarano
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

6.  Optimized mitral annuloplasty ring design reduces loading in the posterior annulus.

Authors:  Beatrice E Ncho; Eric L Pierce; Charles H Bloodworth; Akito Imai; Keitaro Okamoto; Yoshiaki Saito; Robert C Gorman; Joseph H Gorman; Ajit P Yoganathan
Journal:  J Thorac Cardiovasc Surg       Date:  2019-05-31       Impact factor: 5.209

7.  Reoperation in mitral valve repair for regurgitant mitral valve disease.

Authors:  Masato Nakajima; Kouji Tsuchiya; Hideki Sasaki; Narutoshi Hibino; Yuji Naito; Hidenori Inoue; Eiki Mizutani
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-06

8.  Suture dehiscence and collagen content in the human mitral and tricuspid annuli.

Authors:  Immanuel David Madukauwa-David; Eric L Pierce; Fatiesa Sulejmani; Joshua Pataky; Wei Sun; Ajit P Yoganathan
Journal:  Biomech Model Mechanobiol       Date:  2018-10-04

9.  How Local Annular Force and Collagen Density Govern Mitral Annuloplasty Ring Dehiscence Risk.

Authors:  Eric L Pierce; Andrew W Siefert; Deborah M Paul; Sarah K Wells; Charles H Bloodworth; Satoshi Takebayashi; Chikashi Aoki; Morten O Jensen; Matthew J Gillespie; Robert C Gorman; Joseph H Gorman; Ajit P Yoganathan
Journal:  Ann Thorac Surg       Date:  2016-04-28       Impact factor: 4.330

10.  Mitral valve leaflet response to ischaemic mitral regurgitation: from gene expression to tissue remodelling.

Authors:  Daniel P Howsmon; Bruno V Rego; Estibaliz Castillero; Salma Ayoub; Amir H Khalighi; Robert C Gorman; Joseph H Gorman; Giovanni Ferrari; Michael S Sacks
Journal:  J R Soc Interface       Date:  2020-05-06       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.